Obesity and Liver Cancer
- PMID: 27909908
- DOI: 10.1007/978-3-319-42542-9_10
Obesity and Liver Cancer
Abstract
Obesity and related metabolic disorders have become globally prevalent posing a challenge for the chronically damaged liver and predisposing the development and progression of cancer. The rising phenomenon of "obesity epidemic" may provide means for understanding why liver cancer is one of the few malignancies with rising incidence in developed countries over the last decades. Non-alcoholic fatty liver disease associated with obesity, insulin resistance, and type 2 diabetes is an increasingly recognized trigger for liver cancer in Western populations characterized by low prevalence of established risk factors for liver cancer such as viral hepatitis and hepatotoxin exposure. Accumulating evidence has established an association between higher body mass index as an indicator of general obesity and higher risk of primary liver cancer. The associations are stronger in men, in patients with underlying liver disease and in white ethnic groups. Abdominal obesity, weight gain in adult life and metabolic factors related to visceral fat accumulation were also suggested as important risk factors for liver cancer; however, more studies are needed to evaluate these associations. The association of obesity and metabolic parameters with liver cancer survival remains controversial. It is unclear which exact mechanisms could provide links between obesity and liver cancer risk. Recent evidence has implicated several molecular pathways in obesity-associated liver cancer. These include insulin resistance leading to increased levels of insulin and insulin-like growth factors, chronic inflammation, adipose tissue remodeling, pro-inflammatory cytokine and adipokine secretion, and altered gut microbiota. These mechanisms coincide with inflammatory and metabolic processes occurring in non-alcoholic fatty liver disease predisposing cancer development and progression. In the context of the current evidence, better understanding of the role of obesity and related metabolic factors may help in improving current strategies for liver cancer prevention.
Keywords: Inflammation; Liver cancer; Metabolic factors; Non-alcoholic fatty liver disease; Obesity; Prevention.
Similar articles
-
Obesity-associated mechanisms of hepatocarcinogenesis.Metabolism. 2014 May;63(5):607-17. doi: 10.1016/j.metabol.2014.01.011. Epub 2014 Feb 5. Metabolism. 2014. PMID: 24629562 Review.
-
Obesity Biomarkers, Metabolism and Risk of Cancer: An Epidemiological Perspective.Recent Results Cancer Res. 2016;208:199-217. doi: 10.1007/978-3-319-42542-9_11. Recent Results Cancer Res. 2016. PMID: 27909909 Review.
-
Obesity and Endometrial Cancer.Recent Results Cancer Res. 2016;208:107-136. doi: 10.1007/978-3-319-42542-9_7. Recent Results Cancer Res. 2016. PMID: 27909905 Review.
-
Obesity and Ovarian Cancer.Recent Results Cancer Res. 2016;208:155-176. doi: 10.1007/978-3-319-42542-9_9. Recent Results Cancer Res. 2016. PMID: 27909907 Review.
-
Obesity and Breast Cancer.Recent Results Cancer Res. 2016;208:43-65. doi: 10.1007/978-3-319-42542-9_3. Recent Results Cancer Res. 2016. PMID: 27909901 Review.
Cited by
-
Severe loss of visceral fat and skeletal muscle after chemotherapy predicts poor prognosis in metastatic gastric cancer patients without gastrectomy.J Cancer. 2020 Mar 5;11(11):3310-3317. doi: 10.7150/jca.37270. eCollection 2020. J Cancer. 2020. PMID: 32231736 Free PMC article.
-
The Relation of Obesity-Related Hormonal and Cytokine Levels With Multiple Myeloma and Non-Hodgkin Lymphoma.Front Oncol. 2018 Apr 16;8:103. doi: 10.3389/fonc.2018.00103. eCollection 2018. Front Oncol. 2018. PMID: 29713614 Free PMC article. Review.
-
Mortality disparities: A comparison with the Haudenosaunee in New York State.Cancer Health Disparities. 2018;2:10.9777/chd.2018.10009. doi: 10.9777/chd.2018.10009. Epub 2018 Jun 29. Cancer Health Disparities. 2018. PMID: 31777774 Free PMC article.
-
Identification of hub genes associated with obesity-induced hepatocellular carcinoma risk based on integrated bioinformatics analysis.Med Oncol. 2021 Apr 26;38(6):63. doi: 10.1007/s12032-021-01510-0. Med Oncol. 2021. PMID: 33900477
-
Effects of Obesity on Pro-Oxidative Conditions and DNA Damage in Liver of DMBA-Induced Mammary Carcinogenesis Models.Metabolites. 2017 Jun 8;7(2):26. doi: 10.3390/metabo7020026. Metabolites. 2017. PMID: 28594380 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical